Executive Summary
The Delhi High Court granted an interim injunction favoring M/S Friends Overseas against Swadi Product U.K. Ltd. and others, finding a prima facie case of infringement. The court held that the defendants had misappropriated the plaintiff's well-known mark 'SWADI HOMEMADE,' copying its artistic get up, layout, and trade dress. This action was deemed likely to cause confusion among consumers, thus warranting the continuation of the existing restraint order until the final disposal of the suit.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court. Understanding the court's reasoning in M/S Friends Overseas vs Swadi Product U.K. Ltd. & Ors. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Merck Sharp & Dohme CorpvsSanjeev Gupta
The commercial suit for patent infringement concerning Sitagliptin (protected by IN 209816) was settled between Merck Sharp & Dohme Corp and Sanjeev Gupta & Ors. The Defendants acknowledged the validity of the patent and agreed to cease all infringing activities, including manufacturing generic versions, until the patent expires.
Kba Notasys SavsController General Of Patents, Designs and Trademarks and Anr
The appellant, Kba Notasys Sa, challenged an impugned order issued by the Controller General of Patents. The appellant argued that the Controller failed to apply established guidelines for determining inventive step and did not properly assess the invention described in their drawings. The respondent contended that the claimed invention was not patentable as it was covered by existing prior art.
Manu ChaudharyvsController Of Patents
Manu Chaudhary appealed against the Controller of Patents' order dated May 31, 2023, which refused his patent application (No. 2545/DEL/2010). The refusal was based on non-fulfillment of various sections of the Patents Act, 1970. The court issued notice and listed the matter for further hearings.
Kent Ro Systems LtdvsKanchan Singh
The plaintiffs seek a permanent injunction against the defendants for infringing their trademark 'KENT' and registered design no. 312406 related to water purifiers. The plaintiffs allege that the defendants are selling products that are identical or deceptively similar to their registered designs.
Boehringer Ingelheim International GmbH & Anr.vsFemilab Healthcare & Anr.
Boehringer Ingelheim filed an application seeking permanent injunction to restrain Femilab Healthcare from infringing Patent No. 268846 related to Empagliflozin and its formulations. The court, relying on Supreme Court precedents (Novartis v. Natco), observed that the patent in issue had already expired. Consequently, the interim protection granted earlier was vacated.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.